As of 2025-06-01, the Fair Value of Celon Pharma SA (CLN.WA) is -4.07 PLN. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 22.00 PLN, the upside of Celon Pharma SA is -118.51%.
With the market price of 22.00 PLN and our fair value calculation, Celon Pharma SA (CLN.WA) is not a good investment. Investing in CLN.WA stocks now will result in a potential loss of 118.51%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -0.92 | -11.61 | -39.28 | -28.12 | -34.45 | -22.87 |
| YoY growth | -107.68% | -1,165.76% | -238.39% | 28.40% | -22.48% | -301.18% |
| Market Cap (mil) | 1,184.92 |
| P/E | |
| Forward P/E |
| EPS | -0.81 |
| Avg earnings growth rate | -301.18% |
| TTM earnings | -43.86 |